Investment & M&A transaction comps
Skin Care Investment & M&A Transaction Comps
Explore investment and M&A transactions tagged skin care. Compare companies, buyers, dates and available valuation multiples, with reported, estimated or rumored figures clearly labelled in each comp.
Coverage includes published FundComb transactions carrying this tag. Each comp preserves its own source notes and valuation basis.
- Reviewed transactions
- 42
- With value data
- 35
- With revenue multiples
- 34
- Transaction years
- 2015–2026
Sortable transaction comps
Skin Care transaction table
Rows with reported value
22 / 25
Acquisition EV, USD
USD 16B
Investment EV, USD
USD 278M
Median EV / revenue
4.6x
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
25 shown of 42 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Saltair Control | 2026-07-30 | TSG Consumer | USD 458M Estimated Valuation | 458 | 4.6x | 15.3x | Los Angeles, California, USA | Confirmed 2 sources | ||
| rhode Control | 2025-05-28 | e.l.f. Beauty | USD 800M Closing Consideration | 800 | 3.8x | - | United States | Confirmed 3 sources | ||
| Minimalist Control (91%) | 2025-01-22 | Hindustan Unilever | INR 30B Pre Money Enterprise Value | 342 | 5.9x | - | India | Confirmed 3 sources | ||
| Ultra Violette Capital Raise | 2024-01-23 | Aria Growth Partners | AUD 15.0M Investment Amount | 10 | - | - | Australia | Confirmed 1 source | ||
| RoC Skincare Control | 2024-01-23 | Bridgepoint | EUR 462M Enterprise Value | 511 | 3.3x | 20.0x | - | Estimated 1 source | ||
| Dr. Barbara Sturm Control | 2024-01-01 | Puig | EUR 320M Enterprise Value | 354 | 5.0x | - | - | Estimated 2 sources | ||
| Go-To Skincare Control (50%) | 2023-12-15 | Zoë Foster Blake | AUD 43.5M Enterprise Value | 29 | - | - | Australia | Confirmed 2 sources | ||
| COSRX Control (38%) | 2023-10-30 | Amorepacific | USD 1.0B Enterprise Value | 1,000 | 3.6x | - | South Korea | Confirmed 2 sources | ||
| La Rosée Minority (20%) | 2023-09-09 | FG Bros | EUR 250M Enterprise Value | 268 | 4.5x | 14.2x | - | Confirmed 1 source | ||
| Naturium Control | 2023-08-29 | Elf | EUR 328M Enterprise Value | 354 | 3.9x | 20.9x | US (California) | Estimated 1 source | ||
| Bondi Sands Control | 2023-08-01 | Kao Corporation | AUD 450M Consideration | 298 | 4.2x | - | Australia | Confirmed 1 source | ||
| Aesop Control | 2023-04-03 | L’Oréal | EUR 2.2B Consideration | 2,500 | 4.4x | 24.7x | Australia | Confirmed 2 sources | ||
| Brand Gallinée Control | 2022-09-28 | Shiseido | Undisclosed | Undisclosed | - | - | - | Confirmed 1 source | ||
| Skinbetter Science Control | 2022-09-23 | L’Oréal | USD 858M Enterprise Value | 858 | 8.2x | - | United States | Confirmed 1 source | ||
| Hero Cosmetics Control | 2022-09-06 | Church & Dwight | USD 630M Consideration | 630 | 5.5x | 14.0x | United States | Estimated 3 sources | ||
| Tata Harper Control | 2022-09-01 | Amorepacific | EUR 125M Enterprise Value | 125 | 2.8x | 24.5x | United States | Confirmed 1 source | ||
| Ilia Beauty Control | 2022-02-01 | Courtin-Clarins family / Clarins | EUR 612M Enterprise Value | 689 | 7.0x | 20.0x | - | Estimated 2 sources | ||
| Tula Control | 2022-01-04 | P&G | Undisclosed Undisclosed | Undisclosed | 6.7x | - | United States | Estimated 1 source | ||
| Chantecaille Control | 2021-12-21 | Beiersdorf | EUR 609M Enterprise Value | 688 | 4.6x | 15.3x | - | Confirmed 1 source | ||
| Supergoop Control | 2021-12-20 | Blackstone | EUR 618M Enterprise Value | 697 | 5.8x | - | United States | Confirmed 1 source | ||
| E45 Control | 2021-12-01 | Karo Healthcare | Undisclosed | Undisclosed | 4.7x | - | - | Confirmed 1 source | ||
| Sol de Janeiro Control (83%) | 2021-11-15 | L'Occitane | USD 450M Estimated Enterprise Value | 450 | 7.5x | 20.7x | United States | Estimated 5 sources | ||
| Obagi Control | 2021-11-15 | Waldencast | EUR 756M Enterprise Value | 865 | 4.5x | 17.2x | - | Confirmed 1 source | ||
| Héra / HRA Pharma Control | 2021-09-08 | Perrigo | USD 2.1B | 2,100 | 4.5x | - | - | Estimated 3 sources | ||
| Paula's Choice Control | 2021-06-14 | Unilever | USD 2.0B | 2,000 | 6.7x | 18.0x | - | Estimated 1 source |
Explore related tags
Continue to the full transaction history for each tag.
Explore buyers & investors
Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.